Name:	inmb_AggregatePurchasePriceForExerciseOfOption
Namespace Prefix:	inmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Represents information related to expiry date of warrants exercise price based on a valuation.

No definition available.

Name:	inmb_ExpiryDateOfWarrantsExercisePriceBasedOnAValuation
Namespace Prefix:	inmb_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

It represents carrying amount of the balance sheet date of goods and services taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.

No definition available.

Name:	inmb_GoodsAndServicesTaxReceivable
Namespace Prefix:	inmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

It represents information about non-refundable fee.

No definition available.

Name:	inmb_NonRefundableFee
Namespace Prefix:	inmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

Name:	inmb_ResearchAndDevelopmentActivityTextualAbstract
Namespace Prefix:	inmb_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Information about value added tax reimbursements.

No definition available.

Name:	inmb_ValueAddedTaxReimbursements
Namespace Prefix:	inmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

It represents information about warrants and rigts percentage.

No definition available.

Name:	inmb_WarrantsAndRightsPercentage
Namespace Prefix:	inmb_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

It represents information about exercise price based on a valuation exercise price based on a valuation of the Company.

No definition available.

Name:	inmb_WarrantsExercisePriceBasedOnValuation
Namespace Prefix:	inmb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Discount on common shares, or any unamortized balance thereof, shown separately as a deduction from the applicable account(s) as circumstances require.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.4-07)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187103-122770

Name:	us-gaap_CommonStockDiscountOnShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Name:	us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Name:	us-gaap_IncomeTaxReconciliationTaxExemptIncome
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.

No definition available.

Name:	us-gaap_ResearchAndDevelopmentInProcess
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Name:	us-gaap_ValueAddedTaxReceivable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

No definition available.

Name:	us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=inmb_XencorInc.LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_StatementGeographicalAxis=country_GB
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: